MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
+4.55%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$240M
AUM Growth
+$240M
(-0.25%)
Cap. Flow
-$2.16M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
| 1 |
Phathom Pharmaceuticals
PHAT
|
$372K |
Top Sells
| 1 |
OBSV
ObsEva SA Ordinary Shares
OBSV
|
$2.53M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $80.3M | 33.41% | 19,963,157 | – | – |
|
2
Aura Biosciences
AURA
$389M
| $55.1M | 22.93% | 3,039,892 | – | – |
|
3
Vaxcyte
PCVX
$4B
| $45.3M | 18.86% | 1,887,478 | – | – |
|
4
Merus
MRUS
$4.98B
| $32M | 13.34% | 1,600,000 | – | – |
|
|
5
Phathom Pharmaceuticals
PHAT
$864M
| $27.5M | 11.46% | 2,484,274 +33,595 | +1% | +$372K |
|
|
OBSV
6
DELISTED
ObsEva SA Ordinary Shares
OBSV
| – | – | -1,570,000 | Closed | -$2.53M |
|
|
CMPI
7
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| – | – | 0 | – | – |
|